Sign in Subscribe
Cancer

Nonviral Gene Delivery System for Cancer Gene Therapy

Strategic Insights

— 1 min read

A nonviral gene delivery system using a composite of piggyBac (PB) transposon and polyethylenimine (PEI) was developed to support stable genomic integration and persistent gene expression in vivo. In a study published in BMC Cancer, researchers from Fudan University successfully applied this system to treat ovarian cancer in mice. The system was able to achieve long-term transgene expression and reduce tumor volume significantly, with an 81.96% tumor inhibitory rate compared to 43.07% in the control group.

Key Takeaways:

  • The nonviral gene delivery system using PB transposon and PEI was more efficient and stable than viral vectors in cancer gene therapy.
  • The PB/PEI system was able to achieve long-term transgene expression, with mRFP1 expression visualized three weeks after the last transfection.
  • The antitumor effects of the HSV-tk/GCV system were observed after intraperitoneal injection of GCV, with extensive necrosis and lymphocytes infiltration in the tumor tissue.
  • Histological analysis and TUNEL assay confirmed the apoptosis of transfected cells in vivo.
  • The PB/PEI system was able to significantly reduce tumor volume, with an 81.96% tumor inhibitory rate compared to 43.07% in the control group.
  • The study demonstrates the potential of the nonviral gene delivery system as an efficient tool for gene therapy in ovarian cancer.
  • The system was developed by Y. Kang and colleagues at Fudan University.
  • The study was published in BMC Cancer in 2009.

Statistics:

  • 81.96% tumor inhibitory rate in the PB/TK group compared to 43.07% in the control group.
  • 3 weeks: the duration of mRFP1 expression after the last transfection.
  • 81.96%: the tumor inhibitory rate achieved by the PB/PEI system.
  • 43.07%: the tumor inhibitory rate in the control group.
  • 126: the article number in the BMC Cancer journal where the study was published.

Sources:

  • [1] Kang, Y., et al. (2009). Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine. BMC Cancer, 9():126.
  • Cancer Gene Therapy Week (2009). Nonviral gene delivery system for cancer gene therapy. Cancer Gene Therapy Week via NewsRx.com.
  • Fudan University (no date). Department of Obstetrics & Gynecology, Fudan University, Obstetrics & Gynecology Hospital, Shanghai 200011, People's Republic of China.

Read more